Sichuan Kelun Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sichuan Kelun Pharmaceutical Company Limited with three other
companies in this sector in China:
North China Pharmaceutical, Limited
sales of 7.90 billion Chinese Renmimbi [US$1.14 billion]
of which 40%
was Chemical Preparation Medicine),
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(7.90 billion Chinese Renmimbi [US$1.14 billion]
of which 95%
was Pharmaceutical), and
Chongqing Taiji Industry (Group)
(7.16 billion Chinese Renmimbi [US$1.04 billion]
of which 56%
Sichuan Kelun Pharmaceutical Company Limited reported sales of 7.76 billion Chinese Renmimbi (US$1.12 billion)
December of 2015.
decrease of 3.2%
versus 2014, when the company's sales were 8.02 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 4.1% decline
in Medical and Pharmaceutical Products, from 7.94 billion Chinese Renmimbi to 7.62 billion Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Other Operating (up 85.3% to 145.55 million Chinese Renmimbi)